Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

Current opinion in investigational drugs (London, England : 2000) - 1 Dec 2010

Butterfield Lisa H, Vujanovic Lazar

Abstract excerpt

Considerable research in the field of immunotherapy for melanoma has demonstrated that this tumor type can be responsive to therapeutic immune activation strategies. In early clinical trials, vaccine strategies using dendritic cells (DCs) and adenovirus (Ad) vectors (AdVs) were safe and immunogenic, and induced clinical responses in a minority of patients. Research from the past several years has yielded an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoviridae
Share to Antigens, Neoplasm
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Dendritic Cells

Share to Immunotherapy

Share to Melanoma, Experimental

Share to Transduction, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 21154122
PMCID: PMC3758558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.PMID 21154122Read ↗

Dendritic cell vaccines in melanoma: from promise to proof?Semantic proximity Read ↗

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSemantic proximity Read ↗

Dendritic cells transfected with adenoviral vectors as vaccines.Semantic proximity Read ↗

A cancer immunotherapy modality based on dendritic cell reprogramming <i>in vivo</i>Semantic proximity Read ↗

Gene-modified dendritic cell vaccines for cancer.Semantic proximity Read ↗

Viral Vector-Based Melanoma Gene TherapySemantic proximity Read ↗

Review: dendritic cell immunotherapy for melanoma.Semantic proximity Read ↗

Overview of melanoma vaccines and promising approaches.Semantic proximity Read ↗

Dendritic cell therapy for skin cancer.Semantic proximity Read ↗

Cellular Immunotherapy with Dendritic Cells in Cancer: Current StatusSemantic proximity Read ↗

Impact of checkpoint blockade on cancer vaccine–activated CD8+ T cell responsesSemantic proximity Read ↗

Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.